There isn’t enough manufacturing capacity for vaccinate the entire US unless the companies decide to ignore the rest of the world.
Pfizer is slated for around 1B doses (500M people treated) next year, or about 10% of the global population.
I would estimate all high risk groups (elderly, front line workers) vaccinated by Q2'21. Then a phased roll out based on risk. If you're a healthy young 25 year old, you'll likely be one of the last to be vaccinated.
Depends on what else gets approved. Best case is both of these are approved this year, with a couple others by the end of January. If that best case happens we could see countries opening up starting in March, with full opening up this summer.
There isn’t enough manufacturing capacity for vaccinate the entire US unless the companies decide to ignore the rest of the world.
Pfizer is slated for around 1B doses (500M people treated) next year, or about 10% of the global population.
I would estimate all high risk groups (elderly, front line workers) vaccinated by Q2'21. Then a phased roll out based on risk. If you're a healthy young 25 year old, you'll likely be one of the last to be vaccinated.